Return to The AAPP Perspective issue main page.< Previous Article  Next Article >

Caitlin McCarthy, PharmD, BCPP
Clinical Associate Professor, Rutgers University Ernest Mario School of Pharmacy, Piscataway, NJ
Clinical Pharmacist, Henry J. Austin Health Center, Trenton, NJ

What is Telehealth and What are the Benefits of Telehealth?

Telehealth is defined by the Health Resources Services Administration as "the use of electronic information and telecommunication technologies to support long-distance clinical health care, patient and professional health-related education, health administration, and public health.” These technologies can include the internet, video conferencing, store-and-forward imaging, media streaming, and land and wireless communications.1

Extensive research in a variety of patient care environments has shown that telehealth can increase access to care and improve outcomes. Established benefits of telehealth include enhanced convenience of care and access to specialty providers and remote services, limited transmission of communicable disease, and improved patient and clinician satisfaction.2,3 Given the benefits of telehealth, many professional medical societies, including professional pharmacy organizations, endorse telehealth.4-8

What Impact has Telehealth Had on Treatment of Mental Disorders?

Telehealth increases access to screening, assessment, treatment, recovery support, crisis support, and medication management across diverse behavioral health and primary care settings. Implementation of telehealth services has been growing steadily over the years, with a rapid increase in utilization seen during the COVID-19 pandemic. For example, during the acute phase of the COVID-19 pandemic (March 13, 2020, to December 17, 2020), telehealth visits for mental health increased by 1019.3% compared to the previous year, an increase that was sustained throughout the postacute phase (December 18, 2020 to August 31, 2022).9

Types of pharmacy services delivered via telehealth for the treatment of mental health conditions vary, but they are similar to what is seen in more traditional in-person practice settings. For example, services include, but are not limited to10-13:

  • Disease-state management
  • Transitional care management
  • Comprehensive medication management
  • Pharmacogenomic, pharmacokinetic, and therapeutic drug monitoring
  • Medication management of specific drugs/drug classes (e.g., long-acting antipsychotics, lithium, clozapine)
  • Patient counseling and education

Common disease states for which psychiatric pharmacy services via telehealth are provided are depression, anxiety, post-traumatic stress disorder, and bipolar disorder. However, the scope of telehealth for treatment of mental health continues to expand. For example, while the utility of telehealth for treatment of serious mental illness (SMI) and substance use disorder (SUD) has been questioned, a growing body of evidence supports the use of telehealth as an appropriate mode for service delivery for patients experiencing either. Various types of treatments, including behavioral activation therapy, cognitive behavioral therapy, cognitive processing therapy, medications for opioid use disorder (MOUD), pharmacotherapy, and medication monitoring, have been successfully delivered via telehealth with modes of delivery including teleconferencing, web-based applications, and telephonic communication.

Modalities for providing medication management for SMI and SUD range, including automated text messages, smart pill containers, mHealth apps, and direct consultations. Multidisciplinary teams often provide such care, incorporating the expertise of mental health and substance use clinicians, MOUD providers, case managers, peers, and pharmacists and pharmacy staff. Outcomes achieved through use of telehealth to provide treatment of SMI and SUD are like those seen for other disease states, including improved health, reduction in symptoms, treatment satisfaction, retention in care, and improved therapeutic alliance. Specifically, pharmacotherapy for SMI and SUD delivered via telehealth has been shown to reduce length of hospitalization and symptomology and improve medication adherence.14

What Steps Can be Taken to Implement Telehealth Services?

While research and clinical experience supports the adoption of telehealth, several challenges can deter clinicians from engaging in such. For example, potential barriers to telehealth include interstate licensure challenges, regulatory issues that vary by state, situations in which in-person visits are more appropriate, challenges of addressing sensitive topics, limited access to technological devices and connectivity issues, variable levels of digital literacy, cultural acceptance, lack of organizational support, and inconsistent funding for telehealth. Therefore, when planning to implement telehealth services, it is important have a clear vision for the services, and consider the following steps to create a successful program:

  1. Determine which service(s) will be provided via telehealth
  2. Identify the target patient population(s)
  3. Create a list of goals and key performance indicators for the program
  4. Devise a system for multi-source feedback to assess program success
  5. Learn about telehealth rules and regulations in the state that is being practiced in
  6. Identify sources of funding for the service(s) and how to bill for services, if applicable
  7. Decide which mode(s) of telehealth to use
  8. Find and utilize the right technology that will serve the provider and patient’s needs
  9. Take inventory of current devices/technology and obtain any needed tools
  10. Clearly delineate staff responsibilities within the program
  11. Develop a plan for continuity of care in the case of technological issues
  12. Create a business case for telehealth and determine how this will be presented to key stakeholders and organizational leadership for support
  13. Create a plan for marketing services

Telehealth is a rapidly expanding modality for the provision of care with a large body of evidence to support its use across a variety of treatment settings and disease states. Despite the potential challenges clinicians may face when implementing telehealth services, by taking intentional steps to implement those services that are in demand and align with patient, institutional, and clinical goals, new telehealth services can be successfully created to meet patient needs.

References

  1. Office for the Advancement of Telehealth. What is Telehealth? Health Resources and Services Administration. Date last reviewed: March 2022. Access November 27, 2023. Available from: https://www.hrsa.gov/telehealth/what-is-telehealth
  2. Department of Health & Human Services. What is telehealth? Health Resources and Services Administration. Updated: July 23, 2023. Access: November 27, 2023. Available from: https://telehealth.hhs.gov/patients/understanding-telehealth
  3. Gajarawala SN, Pelkowski JN. Telehealth benefits and barriers. J Nurse Pract. 2021 Feb;17(2):218-221. doi: 10.1016/j.nurpra.2020.09.013.
  4. Totten AM, McDonagh MS, Wagner JH. The evidence base for telehealth: reassurance in the face of rapid Expansion during the COVID-19 pandemic. White Paper Commentary. (Pacific Northwest Evidence-based Practice Center, Oregon Health & Science University under Contract No. 290-2015-00009-I). AHRQ Publication No. 20-EHC015. Rockville, MD: Agency for Healthcare Research and Quality. 2020.
  5. American Medical Association. COVID-19: AMA's recent and ongoing advocacy efforts. Updated: June 1, 2022. Accessed: November 27, 2023. Available from: https://www-ama-assn-org.proxy.libraries.rutgers.edu/delivering-care/public-health/covid-19-amas-recent-and-ongoing-advocacy-efforts
  6. Committee on Pediatric Workforce, Marcin JP, Rimsza ME, Moskowitz WB. The use of telemedicine to address access and physician workforce shortages. Pediatrics. 2015 Jul;136(1):202-9. doi: 10.1542/peds.2015-1253.
  7. American Association of Nurse Practitioners. Position Statement on Telehealth. American Association of Nurse Practitioners website. Updated: 2022. Accessed: November 27, 2023. Available from: https://www.aanp.org/advocacy/advocacy-resource/position-statements/telehealth
  8. Alexander E, Butler CD, Darr A, et al. ASHP Statement on Telepharmacy. Am J Health Syst Pharm. 2017 May 1;74(9):e236-e241. doi: 10.2146/ajhp170039.
  9. Cantor JH, McBain RK, Ho P, et al. Telehealth and in-person mental health service utilization and ppending, 2019 to 2022. JAMA Health Forum. 2023 Aug 4;4(8):e232645. doi: 10.1001/jamahealthforum.2023.2645.
  10. Leach M, Garcia G, Ganzer N. Implementation and evaluation of a pharmacist-run mental health treatment clinic via clinical video telehealth. Ment Health Clin. 2016 May 6;6(3):159-164. doi: 10.9740/mhc.2016.05.159.
  11. Brearly TW, Goodman CS, Haynes C, et al. Improvement of postinpatient psychiatric follow-up for veterans using telehealth. Am J Health Syst Pharm. 2020 Feb 7;77(4):288-294. doi: 10.1093/ajhp/zxz314.
  12. Barrett M, Ward S, Colvard M. Pharmacist-led telemental health transitions of care clinic improves antidepressant medication continuity posthospitalization. Ment Health Clin. 2020 Nov 5;10(6):381-384. doi: 10.9740/mhc.2020.11.381.
  13. Arain S, Shakori MA, Thorakkattil SA, et al. Implementation of pharmacist-led telepsychiatry services: challenges and opportunities in the midst of COVID-19. J Technol Behav Sci. 2022;7(4):468-476. doi: 10.1007/s41347-022-00266-2.
  14. Substance Abuse and Mental Health Services Administration (SAMHSA). Telehealth for the Treatment of Serious Mental Illness and Substance Use Disorders. SAMHSA Publication No. PEP21-06-02-001 Rockville, MD: National Mental Health and Substance Use Policy Laboratory. Substance Abuse and Mental Health Services Administration, 2021.
Return to The AAPP Perspective issue main page.< Previous Article  Next Article >